Form 8-K - Current report:
SEC Accession No. 0001628280-22-012714
Filing Date
2022-05-05
Accepted
2022-05-05 16:42:18
Documents
13
Period of Report
2022-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K toi-20220429.htm   iXBRL 8-K 37568
  Complete submission text file 0001628280-22-012714.txt   221073

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20220429.xsd EX-101.SCH 2316
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20220429_def.xml EX-101.DEF 16053
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20220429_lab.xml EX-101.LAB 30835
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20220429_pre.xml EX-101.PRE 16736
7 EXTRACTED XBRL INSTANCE DOCUMENT toi-20220429_htm.xml XML 14860
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 22897149
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine